Fluticasone Furoate

API Product
Fluticasone Furoate | Hovione
Product Status:
Commercial
Available Grades:
  • Inhalation
Regulatory Status:
US DMF
Production Sites:
  • Hovione Loures
Product Type:
  • Corticosteroids
CAS Number:
397864-44-7
Modes of Application:
  • Inhalation
  • Nasal
Common Indications:
  • COPD
Last Inspection:
FDA May 2018

Hovione offer Fluticasone Furoate, crystalline form I for development trials with tailor made particle design to best fit your application, yielding Inhalation grade material, featuring a near-perfect particle size distribution reproducibility and low span batch after batch.

Low amorphous content and high stability with >99.60% purity are also features of this API.

With a proven track record in developing and manufacturing high performance APIs Hovione offers a full range of API inhalation, e.g. Vilanterol Trifenatate or Umeclidinium Bromide.

 

 

 


This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties' patent rights.

Highlight

Contact Us

Please contact us if you have inquiries about our offering

https://go.hovione.com/l/47122/2014-08-06/9grc

Related files

Hovione - Integrated Product List
pdf (3.23 MB)
Download

Related Content

Speak Up!

An Ethics Line to enable team members to Speak Up!

Page
Read more

Corticosteroids

Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.

Page
Read more

Dry Powder Inhalation formulation development

Hovione has considerable inhalation experience that allows us to implement strategies including conventional carrier based, neat (drug-alone) or composite particle formulations.

Page
Read more